-
EZ Cap™ Cy5 Firefly Luciferase mRNA Guide
2026-08-20
A scenario-based guide to using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, for more interpretable mRNA delivery, transfection, and cell-response assays. It explains dual fluorescence–bioluminescence readouts, handling parameters, controls, data interpretation, and practical vendor-selection criteria.
-
Ciprofloxacin Promotes RSL3 Ferroptosis via Zinc
2026-08-20
The reference study identifies a context-dependent role for ciprofloxacin in ferroptosis: unlike its previously reported protection against erastin-induced ferroptosis, ciprofloxacin sensitizes cancer cells to RSL3 through mitochondrial DNA stress and zinc accumulation. The work connects the STING1–CAV2 pathway with mitochondrial Zn2+ handling and reactive oxygen species, providing a mechanistic framework for studying antibiotic–ferroptosis interactions.
-
IWP-L6: Reading Wnt Assays at the Right Level
2026-08-19
IWP-L6 is a potent Porcupine inhibitor for dissecting how Wnt ligand maturation controls developmental, regenerative, and metabolic phenotypes. This article presents an assay-design framework that separates ligand production, pathway reception, and downstream metabolic response.
-
LY294002: PI3K Pathway Workflows
2026-08-19
Build more informative PI3K experiments with LY294002 by linking dose, timing, pathway readouts, apoptosis, autophagy, and angiogenesis phenotypes. This workflow-oriented guide also translates zebrafish vascular findings into practical assay design while highlighting reversibility and off-target considerations.
-
5X Protein Loading Buffer (Reducing) Protocol
2026-08-18
5X Protein Loading Buffer (Reducing) supports consistent protein sample preparation for reducing SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and bromophenol blue. It is intended for denaturing protein molecular weight separation and should not be used when native structure or non-reducing disulfide states must be preserved.
-
ATRX-Deficient Glioma and PDGFR Inhibitor Sensitivity
2026-08-18
The 2022 Cancers study identified ATRX deficiency as a potential biomarker of increased sensitivity to selected receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide studies pairing targeted inhibition with temozolomide.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-08-17
Build reproducible PTEN-restoration experiments with a Cap 1, pseudouridine-modified reagent designed for efficient mammalian translation. This guide connects practical mRNA handling and nanoparticle screening with cancer research assays focused on PI3K/Akt signaling and trastuzumab resistance.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-08-17
Build faster, cleaner reporter experiments with a Cap1- and poly(A)-optimized mRNA that provides a direct readout of delivery and translation. This guide connects routine luciferase workflows with mechanistic studies of PKM2–TGF-β1 signaling, while emphasizing controls, normalization, and troubleshooting.
-
D-Luciferin Potassium Salt for BLI
2026-08-16
D-Luciferin potassium salt is a water-soluble firefly luciferase substrate for in vivo bioluminescence imaging and in vitro reporter assays. Its defined reaction requirements, product specifications, and workflow limits support reproducible tumor cell tracking and ATP assay development.
-
Doxycycline Hyclate for BBB and MMP Research
2026-08-15
Doxycycline hyclate gives neurovascular researchers a practical pharmacological tool for testing how MMP activity contributes to blood-brain barrier failure, neuronal apoptosis, and cognitive dysfunction. This workflow translates a mouse arsenic-exposure study into coordinated permeability, tight-junction, enzymatic, and behavioral assays.
-
EZ Cap™ Firefly Luciferase mRNA Guide
2026-08-14
A scenario-based laboratory guide to using EZ Cap™ Firefly Luciferase mRNA (SKU R1018) in viability, proliferation, cytotoxicity, delivery, and reporter assays. It explains Cap1 biology, handling, controls, data interpretation, LNP-related variables, and practical product-selection criteria.
-
STING agonist-1: Assay Workflow Guide
2026-08-14
Build reproducible STING pathway experiments with a DMSO-soluble small molecule designed for innate immune activation. This guide connects concentration-response testing, type I interferon readouts, and the CD40–STING–TRAF2–IRF4 axis to practical cancer immunotherapy research while emphasizing controls and troubleshooting.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflows
2026-08-13
Build clearer mRNA delivery experiments by pairing direct Cy5 tracking with Firefly Luciferase expression in the same transcript. This workflow separates uptake, intracellular localization, and translation so researchers can optimize delivery materials, including peptide coacervates, with fewer ambiguous results.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-13
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG in ICC/IF, frozen and paraffin IHC, flow cytometry, and fluorescence-based ELISA workflows. It should be paired with validated goat IgG primary antibodies and should not be treated as a direct antigen probe or as a universal secondary for non-goat immunoglobulins.
-
CBD Mechanisms in Orofacial Inflammatory Pain
2026-08-12
A 2026 Brain Research Bulletin study shows that cannabidiol reduces inflammatory pain while also improving anxiety-like, depression-like, and cognitive abnormalities in mice. Its main innovation is the integration of peripheral CB2 signaling, central CB1-associated endocannabinoid changes, and serotonin dynamics in the central amygdala to explain both sensory and affective effects.